SK bioscience Co.,Ltd. (KRX:302440)
South Korea · Delayed Price · Currency is KRW 36,500
-1,250 (-3.31%)
At close: Aug 21, 2026
SK bioscience Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 659,267 | 651,368 | 267,545 | 369,506 | 456,726 | 929,001 |
Revenue Growth | 23.25% | 143.46% | -27.59% | -19.10% | -50.84% | - |
Gross Profit Gross Profit Growth | 93,527 | 75,177 | 30,079 | 141,824 | 239,283 | 570,033 |
Operating Income Operating Income Growth | -131,253 | -123,502 | -138,431 | -11,988 | 115,014 | 474,220 |
Net Income Net Income Growth | -84,699 | -57,424 | -53,881 | 22,318 | 122,452 | 355,139 |
Earnings Per Share EPS Growth | -1080.54 | -733.00 | -698.00 | 290.00 | 1590.00 | 4810.00 |
EPS Growth | - | - | - | -81.76% | -66.94% | - |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
America America Growth | 98,372 | 24,799 | 185,961 | 217,834 | 48,408 |
Europe Europe Growth | 401,375 | 107,124 | 21,202 | 13,778 | 184,500 |
Asia Asia Growth | 10,232 | 3,551 | 3,893 | 651.33 | 233.27 |
South Korea South Korea Growth | 140,120 | 131,495 | 158,217 | 224,157 | 695,859 |
Middle East Middle East Growth | 1,269 | 576.98 | 231.61 | 305.04 | - |
Total Total Growth | 651,368 | 267,545 | 369,506 | 456,726 | 929,001 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 832,602 | 906,301 | 1,158,108 | 1,274,141 | 1,480,806 | 1,645,663 |
Total Debt Total Debt Growth | 543,366 | 469,988 | 392,814 | 20,574 | 113,336 | 106,236 |
Net Cash (Debt) Net Cash Growth | 289,236 | 436,313 | 765,294 | 1,253,568 | 1,367,469 | 1,539,428 |
Net Cash Growth | -58.36% | -42.99% | -38.95% | -8.33% | -11.17% | - |
Net Cash Per Share Net Cash Per Share Growth | 3689.16 | 5567.64 | 9912.96 | 16277.20 | 17754.39 | 20850.38 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 4,467 | 102,507 | -128,020 | 29,346 | -124,958 | 536,594 |
Capital Expenditures CapEx Growth | -139,216 | -183,091 | -164,413 | -43,461 | -72,993 | -42,907 |
Free Cash Flow Free Cash Flow Growth | -134,749 | -80,584 | -292,433 | -14,114 | -197,951 | 493,686 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 14.19% | 11.54% | 11.24% | 38.38% | 52.39% | 61.36% |
Operating Margin | -19.91% | -18.96% | -51.74% | -3.24% | 25.18% | 51.05% |
Pretax Margin | -15.35% | -13.18% | -33.31% | 1.98% | 31.03% | 50.71% |
Profit Margin | -12.85% | -8.82% | -20.14% | 6.04% | 26.81% | 38.23% |
FCF Margin | -20.44% | -12.37% | -109.30% | -3.82% | -43.34% | 53.14% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 23, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | - | - | 247.72 | 46.09 | 48.47 |
Forward PE | - | 173.78 | 173.78 | 173.78 | 24.69 | 23.37 |
P/FCF Ratio | - | - | - | - | - | 34.87 |
PS Ratio | 4.34 | 5.80 | 14.76 | 14.96 | 12.36 | 18.53 |